Brief: Thor Medical Signs Sales Agreement For Thorium-228
June 16 (Reuters) - Thor Medical ASA TRMED.OL: THOR MEDICAL SIGNS STRATEGIC SALES AGREEMENT FOR THORIUM-228 WITH GLOBAL LEADER IN TARGETED ALPHA THERAPY FIVE-YEAR SUPPLY AGREEMENT REPRESENTS REVENUES OF APPROXIMATELY NOK 200 MILLION (USD 20 MILLION) FOR THOR MEDICAL Source text: ID:nObiGwFMJa Further company coverage: TRMED.OL (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln